Germany· DE-A57-0092bc033cdb49f5
Dantamacrin
A dantrolene product containing dantrolene sodium, registered in Germany by Norgine B.V.. The same ATC class is registered in 16 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Dantrolene is registered in 16 of 19 countries.
Countries holding a registration under ATC M03CA01 (dantrolene), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 9 of them publish a price we can compare per daily dose
Dantrolene · ATC M03CA01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dantrolene costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), the median price runs from $1.64 in United States to $5.92 in Finland — a ×3.6 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Dantrolene · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- FI Finland$5.92
- US United States$1.64 (acquisition cost)
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Dantrolene Sodium
- Manufacturer
- Norgine B.V.
- Country
- Germany (DE)
- ATC code
- M03CA01
- ATC class
- Dantrolene
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
93 interactions on record for dantrolene.
Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dantrolene · interactions on record
93 records
- 16 severe
- 60 moderate
- 17 info
Most severe, free to view
- Levonorgestrel and ethinylestradiolG03AA07severe
- Desogestrel and ethinylestradiolG03AA09severe
- Drospirenone and ethinylestradiolG03AA12severe
- EthinylestradiolG03CA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dantrolene in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAgilus 120mg powder for solution for injection vialsForum Health Products Ltd
- United StatesDantriumPar Health USA, LLC
- SwitzerlandAgilus 120 mg, Pulver zur Herstellung einer InjektionslösungNorgine AG
- FranceAGILUS 120 mg, poudre pour solution injectableNORGINE (PAYS-BAS)
- IrelandAgilus 120 mg powder for solution for injectionNorgine B.V.
- CanadaDANTRIUM CAPSULESENDO OPERATIONS LTD.
- NetherlandsAgilus 120 mg poeder voor oplossing voor injectieNorgine B.V.
- FinlandAgilusOrifarm Oy
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Belgium · Dantrium Iv
- France · Dantrium, Dantrium Intraveineux
- United Kingdom (Northern Ireland) · Agilus, dantrium
- Ireland · Dantrium
- Iceland · Agilus
- Italy · Dantrium
- Liechtenstein · Agilus
- Netherlands · Dantrium
- Norway · Agilus
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/131b96a8-557c-4838-be0e-cb918ca411f1 GET /v1/drugs/131b96a8-557c-4838-be0e-cb918ca411f1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Dantrolene Sodium",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about dantrolene.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.